Prognostic significance of preoperative skeletal muscle status in patients with gastric cancer after radical gastrectomy

被引:8
作者
Hu, Chun-lei [1 ]
Jin, Xing-han [1 ]
Yuan, Zhi-dong [2 ]
Xiong, Shao-wei [1 ]
Zhang, Lin [3 ,4 ]
Hou, Jia-ning [1 ]
Ao, Sheng [1 ]
Wu, Jian-long [1 ]
Shi, Han-ping [5 ]
Ji, Jia-fu [6 ]
Lyv, Guo-qing [1 ]
机构
[1] Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Peking Univ Shenzhen Hosp, Dept Gastrointestinal Surg,Med Ctr, Shenzhen, Peoples R China
[2] Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Peking Univ Shenzhen Hosp, Dept Radiol,Med Ctr, Shenzhen, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Clin Lab, Beijing, Peoples R China
[4] Peking Union Med Coll, Beijing, Peoples R China
[5] Peking Univ, Capital Med Univ, Clin Med Coll 9, Beijing Shijitan Hosp, Beijing, Peoples R China
[6] Minist Educ, Key Lab Carcinogenesis & Translat Res, Gastrointestinal Canc Ctr, Beijing, Peoples R China
关键词
gastric cancer; skeletal muscle index; body composition; sarcopenia; overall survival; NUTRITIONAL-STATUS; CLINICAL-IMPLICATIONS; SARCOPENIC OBESITY; ELDERLY-PATIENTS; COMPLICATIONS; MORTALITY; SURVIVAL; PREVALENCE; MORBIDITY; STRENGTH;
D O I
10.6133/apjcn.201909_28(3).0003
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background and Objectives: The association between skeletal muscle status and gastric cancer (GC) prognosis remains unclear. Here, we investigated the impact of the skeletal muscle index (SMI) on overall survival (OS) in GC patients after radical gastrectomy. Methods and Study Design: We divided 178 patients into four groups: adult men, adult women, elderly men and elderly women. The SMI, calculated using CT images, of patients was graded using cutoff values of group-specific tertiles. Age, body mass index, SMI grade, Charlson comorbidity index, surgical method (total vs distal gastrectomy), tumor stage, and histological type and differentiation were included in Cox regression models to assess the primary outcome parameter of OS. A new prognostic score for 3-year OS was established by combining the SMI grade and tumor stage, and receiver operating characteristic (ROC) curve analyses were used to determine its predictive reliability. Results: For groups with high, medium, and low SMI grades, the 3-year OS rates were 94.04, 79.08 and 59.09% and 86.09, 70.11 and 49.11% (p<0.001) in patients undergoing distal and total gastrectomy, respectively. In the multivariate analysis, low SMI (hazard ratio (HR) 1.82, 95% confidence interval (CI) 1.14-2.9), advanced stage (HR 2.89, 95% CI 1.43-5.83), and total gastrectomy (HR 1.69, 95% CI 0.95-3.01) were independent risk factors for OS (p<0.010). The areas under the ROC curves for the prognostic score were 0.77 (range 0.61-0.93) and 0.76 (range 0.65-0.86) in patients undergoing distal and total gastrectomy, respectively. Conclusions: The preoperative SMI was an independent prognostic factor for long-term survival in GC patients after radical gastrectomy.
引用
收藏
页码:442 / 449
页数:8
相关论文
共 29 条
  • [1] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [2] Role of frailty and nutritional status in predicting complications following total gastrectomy with D2 lymphadenectomy in patients with gastric cancer: a prospective study
    Chen, Fan-Feng
    Zhang, Fei-Yu
    Zhou, Xuan-You
    Shen, Xian
    Yu, Zhen
    Zhuang, Cheng-Le
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2016, 401 (06) : 813 - 822
  • [3] Recent Advances in Sarcopenia Research in Asia: 2016 Update From the Asian Working Group for Sarcopenia
    Chen, Liang-Kung
    Lee, Wei-Ju
    Peng, Li-Ning
    Liu, Li-Kuo
    Arai, Hidenori
    Akishita, Masahiro
    [J]. JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2016, 17 (08) : 767.e1 - 767.e7
  • [4] Report of Incidence and Mortality in China Cancer Registries, 2008
    Chen, Wan-qing
    Zheng, Rong-shou
    Zhang, Si-wei
    Li, Ni
    Zhao, Ping
    Li, Guang-lin
    Wu, Liang-you
    He, Jie
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2012, 24 (03) : 171 - 180
  • [5] Cancer incidence and mortality in China in 2013: an analysis based on urbanization level
    Chen, Wanqing
    Zheng, Rongshou
    Zhang, Siwei
    Zeng, Hongmei
    Zuo, Tingting
    Xia, Changfa
    Yang, Zhixun
    He, Jie
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (01) : 1 - 10
  • [6] Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
    Dindo, D
    Demartines, N
    Clavien, PA
    [J]. ANNALS OF SURGERY, 2004, 240 (02) : 205 - 213
  • [7] Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies
    Dodson, Shontelle
    Baracos, Vickie E.
    Jatoi, Aminah
    Evans, William J.
    Cella, David
    Dalton, James T.
    Steiner, Mitchell S.
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 62, 2011, 2011, 62 : 265 - 279
  • [8] Myopenia-a new universal term for muscle wasting
    Fearon, Kenneth
    Evans, William J.
    Anker, Stefan D.
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2011, 2 (01) : 1 - 3
  • [9] Definition and classification of cancer cachexia: an international consensus
    Fearon, Kenneth
    Strasser, Florian
    Anker, Stefan D.
    Bosaeus, Ingvar
    Bruera, Eduardo
    Fainsinger, Robin L.
    Jatoi, Aminah
    Loprinzi, Charles
    MacDonald, Neil
    Mantovani, Giovanni
    Davis, Mellar
    Muscaritoli, Maurizio
    Ottery, Faith
    Radbruch, Lukas
    Ravasco, Paula
    Walsh, Declan
    Wilcock, Andrew
    Kaasa, Stein
    Baracos, Vickie E.
    [J]. LANCET ONCOLOGY, 2011, 12 (05) : 489 - 495
  • [10] Sarcopenia predicts 1-year mortality in elderly patients undergoing curative gastrectomy for gastric cancer: a prospective study
    Huang, Dong-Dong
    Chen, Xiao-Xi
    Chen, Xi-Yi
    Wang, Su-Lin
    Shen, Xian
    Chen, Xiao-Lei
    Yu, Zhen
    Zhuang, Cheng-Le
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (11) : 2347 - 2356